Common Contracts

98 similar Equity Distribution Agreement contracts by TELA Bio, Inc., Agriforce Growing Systems Ltd., Agrify Corp, others

JET.AI INC. Up to $5,400,000 of Common Stock EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • October 28th, 2024 • Jet.AI Inc. • Air transportation, nonscheduled • New York

Jet.AI Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as sales agent, common stock of the Company, par value $0.0001 per share (the “Common Stock”), having an aggregate offering price of up to $5,400,000 of Common Stock (the Common Stock subject to this Equity Distribution Agreement (this “Agreement”) being referred to herein as the “Shares”) on terms set forth herein. The Shares consist entirely of authorized but unissued Common Stock to be issued and sold by the Company.

AutoNDA by SimpleDocs
AgriFORCE Growing Systems Ltd. Up to $[●] of Common Shares equity distribution AGREEMENT
Equity Distribution Agreement • September 16th, 2024 • Agriforce Growing Systems Ltd. • Prefabricated metal buildings & components • New York

AgriFORCE Growing Systems Ltd., a corporation formed under the Business Corporations Act (British Columbia) (the “Company”), proposes to issue and sell through Maxim Group LLC, as exclusive sales agent (the “Agent”), common shares, no par value per share, of the Company (the “Common Shares”), having an aggregate offering price of up to US$[●] (the Common Shares subject to this Equity Distribution Agreement (this “Agreement”) being referred to herein as the “Shares”) on terms set forth herein and subject to the limitations set forth in Section 2(a) hereof. The Shares consist entirely of authorized but unissued Common Shares to be issued and sold by the Company.

DATA STORAGE CORPORATION Up to $10,600,000 of Common Stock EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • July 18th, 2024 • Data Storage Corp • Services-computer processing & data preparation • New York

Data Storage Corporation, a Nevada corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as sales agent, common stock of the Company, par value $0.001 per share (the “Common Stock”), having an aggregate offering price of up to $10,600,000 of Common Stock (the Common Stock subject to this Equity Distribution Agreement (this “Agreement”) being referred to herein as the “Shares”) on terms set forth herein. The Shares consist entirely of authorized but unissued Common Stock to be issued and sold by the Company.

INSPIREMD, INC. EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • May 31st, 2024 • InspireMD, Inc. • Surgical & medical instruments & apparatus • New York

As further set forth in this agreement (this “Agreement”), InspireMD, Inc., a Delaware corporation (the “Company”), proposes to issue and sell from time to time through Piper Sandler & Co. (the “Agent”), as sales agent, the Company’s common stock, par value $0.0001 per share (the “Common Stock”) (such shares of Common Stock to be sold pursuant to this Agreement, the “Shares”) on terms set forth herein. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in Section 2 of this Agreement on the number of Shares issued and sold under this Agreement shall be the sole responsibility of the Company, and the Agent shall have no obligation in connection with such compliance.

TOP SHIPS INC. Up to US$5,800,000 of Common Shares EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • May 24th, 2024 • Top Ships Inc. • Deep sea foreign transportation of freight • New York

Top Ships Inc., a corporation organized under the laws of the Republic of the Marshall Islands (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as sales agent, common shares of the Company, par value $0.01 per share (the “Common Shares”), having an aggregate offering price of up to US$5,800,000 of Common Shares (the Common Shares subject to this Equity Distribution Agreement (this “Agreement”) being referred to herein as the “Shares”) on terms set forth herein. The Shares consist entirely of authorized but unissued Common Shares to be issued and sold by the Company.

CELLECTAR BIOSCIENCES, INC. EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • May 24th, 2024 • Cellectar Biosciences, Inc. • Pharmaceutical preparations • New York

As further set forth in this agreement (this “Agreement”), Cellectar Bioscience, Inc., a company organized under the laws of Delaware (the “Company”), proposes to issue and sell from time to time through Piper Sandler & Co. (the “Agent”), as sales agent, the Company’s common stock, par value $0.00001 per share (the “Common Stock”) (such shares of Common Stock to be sold pursuant to this Agreement, the “Shares”) on terms set forth herein. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in Section 2 of this Agreement on the number of Shares issued and sold under this Agreement shall be the sole responsibility of the Company, and the Agent shall have no obligation in connection with such compliance.

SKYE BIOSCIENCE, INC. EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • May 10th, 2024 • Skye Bioscience, Inc. • Pharmaceutical preparations • New York

As further set forth in this agreement (this “Agreement”), Skye Bioscience, Inc., a company organized under the laws of Nevada (the “Company”), proposes to issue and sell from time to time through Piper Sandler & Co. (the “Agent”), as sales agent, an aggregate offering amount of up to $100,000,000 of the Company’s common stock, par value $0.001 per share (the “Common Stock”) (such shares of Common Stock to be sold pursuant to this Agreement, the “Shares”) on terms set forth herein. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in Section 2 of this Agreement on the number of Shares issued and sold under this Agreement shall be the sole responsibility of the Company, and the Agent shall have no obligation in connection with such compliance.

Edible Garden AG Incorporated Up to $1,146,893 of Shares of Common Stock Equity Distribution Agreement
Equity Distribution Agreement • February 7th, 2024 • Edible Garden AG Inc • Agricultural production-crops • New York

Edible Garden AG Incorporated, a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (“Maxim”), as sales agent, up to an aggregate of $1,146,893 of shares of common stock, par value $0.0001 per share (“Common Stock”), of the Company (the “Shares”) on terms set forth herein. Maxim may be referred to herein as the “Agent”. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.

ICECURE MEDICAL LTD. Up to US$9,700,000 of Ordinary Shares EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • January 12th, 2024 • IceCure Medical Ltd. • Surgical & medical instruments & apparatus • New York

This Equity Distribution Agreement (this “Agreement”) is entered into between IceCure Medical Ltd., a company formed under the laws of the State of Israel (the “Company”) and Maxim Group LLC (the “Agent”), as sales agent, with respect to the proposed issue and sale by the Company, through the Agent, of ordinary shares of the Company, no par value per share (the “Ordinary Shares”), having an aggregate offering price of up to US$9,700,000 (the Ordinary Shares subject to this Agreement being referred to herein as the “Shares”) on terms set forth herein. The Shares consist entirely of authorized but unissued Ordinary Shares to be issued and sold by the Company.

Sonoma Pharmaceuticals, Inc. Shares of Common Stock (par value, $0.0001 per share) EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • December 18th, 2023 • Sonoma Pharmaceuticals, Inc. • Pharmaceutical preparations • New York

Sonoma Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC, as exclusive sales agent (the “Agent”), shares of common stock, par value $0.0001 per share, of the Company (the “Common Stock”), with the Common Stock subject to this Equity Distribution Agreement (this “Agreement”) being referred to herein as the “Shares”, on terms set forth herein and subject to the limitations set forth in Section 2 hereof. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.

TELA Bio, Inc. EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • November 13th, 2023 • TELA Bio, Inc. • Surgical & medical instruments & apparatus • New York

As further set forth in this agreement (this “Agreement”), TELA Bio, Inc., a company organized under the laws of the State of Delaware (the “Company”), proposes to issue and sell from time to time through Piper Sandler & Co. (the “Agent”), as sales agent, shares of the Company’s common stock, par value $0.001 per share (the “Common Stock” and, such shares of Common Stock to be sold pursuant to this Agreement, the “Shares”) on terms set forth herein. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in Section 2 of this Agreement on the number of shares of Shares issued and sold under this Agreement shall be the sole responsibility of the Company, and the Agent shall have no obligation in connection with such compliance.

TELA Bio, Inc. EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • November 13th, 2023 • TELA Bio, Inc. • Surgical & medical instruments & apparatus • New York

As further set forth in this agreement (this “Agreement”), TELA Bio, Inc., a company organized under the laws of the State of Delaware (the “Company”), proposes to issue and sell from time to time through Piper Sandler & Co. (the “Agent”), as sales agent, shares of the Company’s common stock, par value $0.001 per share (the “Common Stock” and, such shares of Common Stock to be sold pursuant to this Agreement, the “Shares”) on terms set forth herein. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in Section 2 of this Agreement on the number of shares of Shares issued and sold under this Agreement shall be the sole responsibility of the Company, and the Agent shall have no obligation in connection with such compliance.

Nine Energy Service, Inc. Equity Distribution Agreement
Equity Distribution Agreement • November 7th, 2023 • Nine Energy Service, Inc. • Oil & gas field services, nec • New York

As further set forth in this agreement (this “Agreement”), Nine Energy Service, Inc., a company organized under the laws of Delaware (the “Company”), proposes to issue and sell from time to time through Piper Sandler & Co. (the “Agent”), as sales agent, the Company’s common stock, par value $0.01 per share (the “Common Stock”) (such shares of Common Stock to be sold pursuant to this Agreement, the “Shares”) on terms set forth herein. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in Section 2(b) of this Agreement on the number of Shares issued and sold under this Agreement shall be the sole responsibility of the Company, and the Agent shall have no obligation in connection with such compliance.

APPLIED DNA SCIENCES, INC. Up to $6,397,939 of Common Stock EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • November 7th, 2023 • Applied Dna Sciences Inc • Services-testing laboratories • New York

Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC, as exclusive sales agent (the “Agent”), shares of common stock, par value $0.001 per share, of the Company (the “Common Stock”), having an aggregate offering price of up to $6,397,939 (the Common Stock subject to this Equity Distribution Agreement (this “Agreement”) being referred to herein as the “Shares”) on terms set forth herein and subject to the limitations set forth in Section 2 hereof. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.

EuroDry Ltd. Up to $6,680,000 Common Shares Equity Distribution Agreement
Equity Distribution Agreement • October 11th, 2023 • EuroDry Ltd. • Water transportation • New York

EuroDry Ltd., a Marshall Islands corporation (the “Company”), proposes to issue and sell through A.G.P./Alliance Global Partners (the “Agent”), as sales agent, common shares, par value $0.01 per share (“Common Shares”), of the Company having an aggregate offering price of up to $6,680,000 on terms set forth herein (the “Shares”). The Shares consist entirely of authorized but unissued Common Shares to be issued and sold by the Company.

HEART TEST LABORATORIES, INC. Up to $3,250,000 of Common Stock EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • September 18th, 2023 • Heart Test Laboratories, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York

Heart Test Laboratories, Inc., a Texas corporation (the “Company”), proposes to issue and sell through Maxim Group LLC, as exclusive sales agent (the “Agent”), shares of common stock, par value $0.001 per share, of the Company (the “Common Stock”), having an aggregate offering price of up to US$3,250,000 (the Common Stock subject to this Equity Distribution Agreement (this “Agreement”) being referred to herein as the “Shares”) on terms set forth herein and subject to the limitations set forth in Section 2(a) hereof. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.

ESPORTS ENTERTAINMENT GROUP, INC. Up to US$7,186,257 of Common Stock EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • September 18th, 2023 • Esports Entertainment Group, Inc. • Services-amusement & recreation services • New York

Esports Entertainment Group, Inc., a Nevada corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as sales agent, common stock of the Company, par value $0.001 per share (the “Common Stock”), having an aggregate offering price of up to US$7,186,267 of Common Stock (the Common Stock subject to this Equity Distribution Agreement (this “Agreement”) being referred to herein as the “Shares”) on terms set forth herein. The Shares consist entirely of authorized but unissued Common Stock to be issued and sold by the Company.

Up to US$10,000,000 of Class A Ordinary Shares EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • September 11th, 2023 • SAI.TECH Global Corp • Services-computer processing & data preparation • New York

SAI.TECH Global Corporation, a Cayman Islands exempted company (the “Company”), proposes to issue and sell through Maxim Group LLC (“Maxim”), the exclusive agent (the “Agent”), Class A ordinary shares of the Company, par value $0.0001 per share (the “Ordinary Shares”), having an aggregate offering price of up to US$10,000,000 of Ordinary Shares (the Ordinary Shares subject to this Equity Distribution Agreement (this “Agreement”) being referred to herein as the “Shares”) on terms set forth herein. The Shares consist entirely of authorized but unissued Ordinary Shares to be issued and sold by the Company.

CASA SYSTEMS, INC. EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • August 8th, 2023 • Casa Systems Inc • Radio & tv broadcasting & communications equipment • New York

As further set forth in this agreement (this “Agreement”), Casa Systems, Inc., a company organized under the laws of Delaware (the “Company”), proposes to issue and sell from time to time through Piper Sandler & Co. (the “Agent”), as sales agent, the Company’s common stock, par value $0.001 per share (the “Common Stock”) (such shares of Common Stock to be sold pursuant to this Agreement, the “Shares”) on terms set forth herein. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in Section 2 of this Agreement on the number of Shares issued and sold under this Agreement shall be the sole responsibility of the Company, and the Agent shall have no obligation in connection with such compliance.

Up to US$4,700,000 of Common Stock EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • June 27th, 2023 • Lm Funding America, Inc. • Finance services • New York
CASTOR MARITIME INC. Up to US$30,000,000 of Common Shares EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • May 23rd, 2023 • Castor Maritime Inc. • Deep sea foreign transportation of freight • New York

This Equity Distribution Agreement (this “Agreement”) is entered into between Castor Maritime Inc., a corporation organized under the laws of the Republic of the Marshall Islands (the “Company”) and Maxim Group LLC (the “Agent”), as sales agent, with respect to the proposed issue and sale by the Company, through the Agent, of common shares of the Company, par value $0.001 per share (the “Common Shares”), having an aggregate offering price of up to US$30,000,000 (the Common Shares subject to this Agreement being referred to herein as the “Shares”) on terms set forth herein. The Shares consist entirely of authorized but unissued Common Shares to be issued and sold by the Company.

Tenon Medical, Inc. Up to $6,700,000 Shares of Common Stock Equity Distribution Agreement
Equity Distribution Agreement • May 4th, 2023 • Tenon Medical, Inc. • Surgical & medical instruments & apparatus • New York

Tenon Medical, Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as exclusive sales agent, shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Shares”) having an aggregate offering price of up to $6,700,000 on terms set forth herein. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.

AutoNDA by SimpleDocs
CO-DIAGNOSTICS, INC. EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • March 16th, 2023 • Co-Diagnostics, Inc. • Surgical & medical instruments & apparatus • New York

As further set forth in this agreement (this “Agreement”), Co-Diagnostics, Inc., a company organized under the laws of Utah (the “Company”), proposes to issue and sell from time to time through Piper Sandler & Co. (the “Agent”), as sales agent, the Company’s common stock, par value $0.001 per share (the “Common Stock”) (such shares of Common Stock to be sold pursuant to this Agreement, the “Shares”) on terms set forth herein. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in Section 2 of this Agreement on the number of Shares issued and sold under this Agreement shall be the sole responsibility of the Company, and the Agent shall have no obligation in connection with such compliance.

YIELD10 BIOSCIENCE, INC. Up to $4,200,000 of Common Stock EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • January 24th, 2023 • Yield10 Bioscience, Inc. • Agricultural production-crops • New York

Yield10 Bioscience, Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as sales agent, common stock of the Company, par value $0.01 per share (the “Common Stock”), having an aggregate offering price of up to $4,200,000 of Common Stock (the Common Stock subject to this Equity Distribution Agreement (this “Agreement”) being referred to herein as the “Shares”) on terms set forth herein. The Shares consist entirely of authorized but unissued Common Stock to be issued and sold by the Company.

APTOSE BIOSCIENCES INC. EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • December 12th, 2022 • Aptose Biosciences Inc. • Biological products, (no disgnostic substances) • New York

As further set forth in this agreement (this “Agreement”), Aptose Biosciences Inc., a company incorporated under the Canada Business Corporations Act (the “Company”), proposes to issue and sell from time to time through JonesTrading Institutional Services LLC (the “Agent”), as sales agent, the Company’s common shares, no par value per share (the “Common Shares”) (such Common Shares to be sold pursuant to this Agreement, the “Shares”) on terms set forth herein. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in Section 2 of this Agreement on the number of Shares issued and sold under this Agreement shall be the sole responsibility of the Company, and the Agent shall have no obligation in connection with such compliance.

APYX MEDICAL CORPORATION EQUITY DISTRIBUTION AGREEMENT November 22, 2022 PIPER SANDLER & CO. U.S. Bancorp Center 800 Nicollet Mall Minneapolis, Minnesota 55402 Ladies and Gentlemen: As further set forth in this agreement (this “Agreement”), Apyx...
Equity Distribution Agreement • November 22nd, 2022 • Apyx Medical Corp • Surgical & medical instruments & apparatus
AKOYA BIOSCIENCES, INC. EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • November 7th, 2022 • Akoya Biosciences, Inc. • Laboratory analytical instruments • New York

As further set forth in this agreement (this “Agreement”), Akoya Biosciences, Inc., a Delaware corporation (the “Company”), proposes to issue and sell from time to time through Piper Sandler & Co. (the “Agent”), as sales agent, the Company’s common stock, par value $0.00001 per share (the “Common Stock”) (such shares of Common Stock to be sold pursuant to this Agreement, the “Shares”) on terms set forth herein. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in Section 2 of this Agreement on the number of shares of Shares issued and sold under this Agreement shall be the sole responsibility of the Company, and the Agent shall have no obligation in connection with such compliance.

CVRX, INC. EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • November 4th, 2022 • CVRx, Inc. • Surgical & medical instruments & apparatus • New York

As further set forth in this agreement (this “Agreement”), CVRx, Inc., a company organized under the laws of Delaware (the “Company”), proposes to issue and sell from time to time through Piper Sandler & Co. (the “Agent”), as sales agent, the Company’s common stock, par value $0.01 per share (the “Common Stock”), having an aggregate gross offering price of up to $50,000,000 (such shares of Common Stock to be sold pursuant to this Agreement, the “Shares”) on terms set forth herein. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in Section 2 of this Agreement on the number of Shares issued and sold under this Agreement shall be the sole responsibility of the Company, and the Agent shall have no obligation in connection with such compliance.

Agrify Corporation EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • October 18th, 2022 • Agrify Corp • Agricultural services • New York

As further set forth in this agreement (this “Agreement”), Agrify Corporation, a Nevada corporation (the “Company”), proposes to issue and sell from time to time through Canaccord Genuity LLC (the “Agent”), as sales agent, the Company’s common stock, $0.001 par value per share (the “Common Shares”) (such Common Shares to be sold pursuant to this Agreement, the “Shares”), having an aggregate offering price of up to $50,000,000, on terms set forth herein. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in Section 2 of this Agreement on the number of Shares issued and sold under this Agreement shall be the sole responsibility of the Company, and the Agent shall have no obligation in connection with such compliance.

WISA TECHNOLOGIES, INC. Up to $4,000,000 of Common Stock equity distribution AGREEMENT
Equity Distribution Agreement • September 13th, 2022 • Wisa Technologies, Inc. • Semiconductors & related devices • New York

WiSA Technologies, Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC, as sales agent (the “Agent”), shares of common stock, par value $0.0001 per share, of the Company (the “Common Stock”), having an aggregate offering price of up to US$4,000,000 of Common Stock (the Common Stock subject to this Equity Distribution Agreement (this “Agreement”) being referred to herein as the “Shares”) on terms set forth herein and subject to the limitations set forth in Section 2(a) hereof. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.

PLUS THERAPEUTICS, INC. EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • September 9th, 2022 • Plus Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York

As further set forth in this agreement (this “Agreement”), Plus Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell from time to time through Canaccord Genuity LLC (the “Agent”), as sales agent, the Company’s common stock, $0.001 par value per share (the “Common Shares”) (such Common Shares to be sold pursuant to this Agreement, the “Shares”), having an aggregate offering price of up to $5,000,000, on terms set forth herein. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in Section 2 of this Agreement on the number of Shares issued and sold under this Agreement shall be the sole responsibility of the Company, and the Agent shall have no obligation in connection with such compliance.

ALAUNOS THERAPEUTICS, INC. EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • August 12th, 2022 • Alaunos Therapeutics, Inc. • Pharmaceutical preparations • New York

As further set forth in this agreement (this “Agreement”), Alaunos Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell from time to time through Piper Sandler & Co. (the “Agent”), as sales agent, the Company’s common stock, par value $0.001 per share (the “Common Stock”) (such shares of Common Stock to be sold pursuant to this Agreement, the “Shares”) on terms set forth herein. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in Section 2 of this Agreement on the number of Shares issued and sold under this Agreement shall be the sole responsibility of the Company, and the Agent shall have no obligation in connection with such compliance.

IMMUNEERING CORPORATION EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • August 10th, 2022 • Immuneering Corp • Pharmaceutical preparations • New York

As further set forth in this agreement (this “Agreement”), Immuneering Corporation, a Delaware corporation (the “Company”), proposes to issue and sell from time to time through Piper Sandler & Co. (the “Agent”), as sales agent, the Company’s Class A common stock, $0.001 par value per share (the “Common Stock”) (such shares of Common Stock to be sold pursuant to this Agreement, the “Shares”) on the terms set forth herein. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in Section 2 of this Agreement on the number of Shares issued and sold under this Agreement shall be the sole responsibility of the Company, and the Agent shall have no obligation in connection with such compliance.

POINT BIOPHARMA GLOBAL INC. EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • July 1st, 2022 • POINT Biopharma Global Inc. • Pharmaceutical preparations • New York

As further set forth in this agreement (this “Agreement”), POINT Biopharma Global Inc., a company organized under the laws of Delaware (the “Company”), proposes to issue and sell from time to time through Piper Sandler & Co. (the “Agent”), as sales agent, the Company’s common stock, par value $0.0001 per share (the “Common Stock”) (such shares of Common Stock to be sold pursuant to this Agreement, the “Shares”) on terms set forth herein. Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitation set forth in Section 2 of this Agreement on the number of Shares issued and sold under this Agreement shall be the sole responsibility of the Company, and the Agent shall have no obligation in connection with such compliance.

APPLIED UV, INC. Up to US$9,000,000 of Common Stock EQUITY DISTRIBUTION AGREEMENT
Equity Distribution Agreement • July 1st, 2022 • Applied UV, Inc. • Electric lighting & wiring equipment • New York

Applied UV, Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as sales agent, common stock of the Company, par value $0.0001 per share (the “Common Stock”), having an aggregate offering price of up to US$9,000,000 of Common Stock (the Common Stock subject to this Equity Distribution Agreement (this “Agreement”) being referred to herein as the “Shares”) on terms set forth herein. The Shares consist entirely of authorized but unissued Common Stock to be issued and sold by the Company.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!